Akari Therapeutics PLC (AKTX)

2.40 -0.03 (-1.21%) USD  |  NASDAQ  |  Nov 05, 11:24
More

Akari Therapeutics EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
November 01, 2022 --
Date Value
September 30, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

Upgrade
Minimum
Nov 01 2022
Upgrade
Maximum
Sep 30 2022
Upgrade
Average
Upgrade
Median

EPS Estimates for Current Quarter Benchmarks

DBV Technologies SA Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
NuCana PLC Upgrade

EPS Estimates for Current Quarter Related Metrics

EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade